Skip Navigation
Subscribe
Submit a Manuscript
Sign In
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In
|
Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens
|
Shibboleth
|
Log In
SUBSCRIBE
Subscribe to
Annals of Internal Medicine
.
You will be directed to acponline.org to complete your purchase.
Menu
Latest
Issues
Channels
CME/MOC
In the Clinic
Journal Club
Web Exclusives
Author Info
Search
Advanced Search
Platelet Disorders
SORT BY
SORT:
Most Recent
A to Z
By Relevancy
Basic View
Expanded View
NARROW BY
Article Type
Original Research
(84)
Case Reports
(31)
Brief Reports
(16)
Letters
(13)
Editorials
(11)
Reviews
(9)
Summaries for Patients
(9)
Abstracts
(5)
Brief Communications
(5)
Articles
(2)
Diagnosis and Treatment
(2)
ACP Journal Club
(1)
Ideas and Opinions
(1)
Letters and Corrections
(1)
Position Papers
(1)
Web Exclusives
(1)
View More
View Less
Topics
Hematology/Oncology
(192)
Platelet Disorders
(192)
Coagulopathies
(123)
Infectious Disease
(15)
Nephrology
(13)
Red Cell Disorders
(12)
Cardiology
(11)
Hospital Medicine
(10)
Gastroenterology/Hepatology
(9)
Endocrine and Metabolism
(8)
Emergency Medicine
(6)
Coronary Risk Factors
(5)
HIV
(5)
Rheumatology
(5)
Leukemia/Lymphoma
(4)
Lupus Erythematosus
(4)
Rhythm Disorders and Devices
(4)
Tobacco, Alcohol, and Other Substance Abuse
(4)
Diabetes
(3)
Hypertension
(3)
Liver Disease
(3)
Neurology
(3)
Pulmonary/Critical Care
(3)
Thyroid Disorders
(3)
Encephalopathy
(2)
Inflammatory Bowel Disease
(2)
Multiple Myeloma
(2)
Prevention/Screening
(2)
Adrenal Disorders
(1)
Biliary Disorders
(1)
Dyslipidemia
(1)
Education and Training
(1)
Influenza
(1)
Metabolic Bone Disorders
(1)
Multi-Organ Failure and Sepsis
(1)
Neuropathy
(1)
Pneumonia
(1)
Streptococcal Infections
(1)
Valvular Heart Disease
(1)
Vasculitides
(1)
Venous Thromboembolism
(1)
View More
View Less
Reviews
|
1 August 2017
Benefits and Risks of Antithrombotic Therapy in Essential Thrombocythemia: A Systematic Review
View:
Full Text
|
Abstract/Excerpt
Editorials
|
1 August 2017
Are Antiplatelet Agents Beneficial in Essential Thrombocythemia? Maybe Yes, Probably No
View:
Full Text
|
Abstract/Excerpt
ACP Journal Club
|
15 September 2015
In unexplained recurrent pregnancy loss, daily LMWH did not improve ongoing pregnancy or live birth rates
View:
Full Text
|
Abstract/Excerpt
Original Research
|
5 May 2015
Low-Molecular-Weight Heparin for Women With Unexplained Recurrent Pregnancy Loss: A Multicenter Trial With a Minimization Randomization Scheme
View:
Full Text
|
Abstract/Excerpt
Letters
|
2 July 2013
Successful Treatment of the Postpartum Atypical Hemolytic Uremic Syndrome With Eculizumab
View:
Full Text
|
Abstract/Excerpt
Reviews
|
2 January 2007
Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura
View:
Full Text
|
Abstract/Excerpt
Articles
|
5 April 2005
Brief Communication: Duration of Platelet Dysfunction after a 7-Day Course of Ibuprofen
View:
Full Text
|
Abstract/Excerpt
Summaries for Patients
|
7 September 2004
Predicting Which Patients Have Severe Acute Respiratory Syndrome
View:
Full Text
|
Abstract/Excerpt
Reviews
|
20 January 2004
Management of Adult Patients with Persistent Idiopathic Thrombocytopenic Purpura Following Splenectomy: A Systematic Review
View:
Full Text
|
Abstract/Excerpt
Summaries for Patients
|
20 January 2004
Treatment Options for Idiopathic Thrombocytopenic Purpura When Splenectomy Is Ineffective
View:
Full Text
|
Abstract/Excerpt
Articles
|
16 September 2003
The Rate of Progression to Polycythemia Vera or Essential Thrombocythemia in Patients with Erythrocytosis or Thrombocytosis
View:
Full Text
|
Abstract/Excerpt
Summaries for Patients
|
16 September 2003
Polycythemia Vera and Essential Thrombocythemia in a General Population
View:
Full Text
|
Abstract/Excerpt
Brief Communications
|
21 January 2003
Remission of Chronic Thrombotic Thrombocytopenic Purpura after Treatment with Cyclophosphamide and Rituximab
View:
Full Text
|
Abstract/Excerpt
Summaries for Patients
|
21 January 2003
Treatment of Refractory Thrombotic Thrombocytopenic Purpura
View:
Full Text
|
Abstract/Excerpt
Editorials
|
21 January 2003
Thrombotic Thrombocytopenic Purpura: From the Bench to the Bedside, but Not Yet to the Community
View:
Full Text
|
Abstract/Excerpt
« Previous
1
2
3
4
5
Next 16 Results »
Advertisement
This site uses cookies. By continuing to use our website, you are agreeing to
our privacy policy.
|
Accept
×
You need a subscription to this content to use this feature.
×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In
|
Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens
|
Shibboleth
|
Log In
PURCHASE OPTIONS
Buy This Article
|
Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account
|
Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In
|
Set Up Account
You will be directed to acponline.org to register and create your Annals account
CREATE YOUR FREE ACCOUNT
Create Your Free Account
|
Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×